AB
ONCT

Amalgamated Bank’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History

Amalgamated Bank’s Portfolio ONCT Stock Details ONCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-266
Closed -$7K – 3266
2022
Q1 		$7K Buy
+266
New +$9.68K ﹤0.01% 3007

Other funds holding ONCT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
QPW
Quantum Private Wealth Tampa, Florida $324M AUM 37.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BC
BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return
BJL
Brighton Jones LLC Seattle, Washington $2.37B AUM 16.36% 1-Year Est. Return

Amalgamated Bank's ONCT Position: Q2 2022 in Review

Amalgamated Bank sold out of Oncternal Therapeutics, Inc. Common Stock (ONCT) in Q2 2022, closing a stake of 266 shares — an estimated $7K sold.

Amalgamated Bank first reported a position in ONCT in Q1 2022 and held it in 1 quarter. The position peaked at $7K in Q1 2022. 75 funds tracked by Wall St. Rank hold ONCT as of Q2 2022.

  • Amalgamated Bank reported no remaining Oncternal Therapeutics, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Amalgamated Bank sold 266 Oncternal Therapeutics, Inc. Common Stock shares in Q2 2022, an estimated $7K.
  • Amalgamated Bank first reported a position in Oncternal Therapeutics, Inc. Common Stock in Q1 2022 and held it in 1 quarter.
  • Amalgamated Bank's Oncternal Therapeutics, Inc. Common Stock position peaked at $7K in Q1 2022.
  • 75 funds tracked by Wall St. Rank held Oncternal Therapeutics, Inc. Common Stock as of Q2 2022.

Based on Amalgamated Bank's 13F filing for Q2 2022, filed 15 Aug 2022.